1 FUROSEMIDE | 50 of 670 | 1710 prescriptions Less than 1% of all prescriptions | 1160 | 530 patients 19% of all patients | 390 patients 14% of all patients | |
2 PREDNISONE | 190 of 1180 | 2270 prescriptions Less than 1% of all prescriptions | 1550 | 1110 patients 40% of all patients | 730 patients 26% of all patients | |
3 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 430 of 1080 | 1170 prescriptions Less than 1% of all prescriptions | 780 | 340 patients 12% of all patients | < 11 | |
4 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 480 of 1110 | 1090 prescriptions Less than 1% of all prescriptions | 910 | 340 patients 12% of all patients | < 11 | |
5 SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE) | 220 of 920 | 920 prescriptions Less than 1% of all prescriptions | 650 | 220 patients 8% of all patients | < 11 | |
6 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 450 of 1030 | 650 prescriptions Less than 1% of all prescriptions | | 260 patients 9% of all patients | < 11 | |
7 METHYLPREDNISOLONE | 30 of 180 | 940 prescriptions Less than 1% of all prescriptions | 700 | 450 patients 16% of all patients | 280 patients 10% of all patients | |
8 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 320 of 960 | 640 prescriptions Less than 1% of all prescriptions | | 140 patients 5% of all patients | < 11 | |
9 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 550 of 1050 | 360 prescriptions Less than 1% of all prescriptions | 220 | < 11 | < 11 | |
10 VENTOLIN HFA (ALBUTEROL SULFATE) | 620 of 1160 | 690 prescriptions Less than 1% of all prescriptions | 460 | 310 patients 11% of all patients | < 11 | |
11 MONTELUKAST SODIUM | 750 of 1080 | 360 prescriptions Less than 1% of all prescriptions | 140 | < 11 | < 11 | |
12 TORSEMIDE | 10 of 110 | 460 prescriptions Less than 1% of all prescriptions | 330 | 150 patients 5% of all patients | < 11 | |
13 ARNUITY ELLIPTA (FLUTICASONE FUROATE) | 160 of 380 | 340 prescriptions Less than 1% of all prescriptions | 220 | < 11 | < 11 | |
14 TRELEGY ELLIPTA (FLUTICASONE/UMECLIDIN/VILANTER) | 280 of 620 | 240 prescriptions Less than 1% of all prescriptions | | 110 patients 4% of all patients | < 11 | |
15 AZITHROMYCIN | 370 of 920 | 410 prescriptions Less than 1% of all prescriptions | 290 | 210 patients 8% of all patients | < 11 | A |
16 PROAIR HFA (ALBUTEROL SULFATE) | 640 of 1110 | 370 prescriptions Less than 1% of all prescriptions | | 160 patients 6% of all patients | < 11 | |
17 SPIRIVA (TIOTROPIUM BROMIDE) | 670 of 1020 | 150 prescriptions Less than 1% of all prescriptions | 150 | < 11 | < 11 | |
18 BUMETANIDE | 30 of 50 | 200 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
19 METHOTREXATE (METHOTREXATE SODIUM) | 100 of 130 | 160 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
20 SPIRONOLACTONE | 100 of 260 | 230 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
21 FLUTICASONE PROPIONATE | 680 of 990 | 130 prescriptions Less than 1% of all prescriptions | | 120 patients 4% of all patients | < 11 | |
22 DYMISTA (AZELASTINE/FLUTICASONE) | 90 of 170 | 140 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
23 PANTOPRAZOLE SODIUM | 270 of 440 | 140 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
24 BEVESPI AEROSPHERE (GLYCOPYRROLATE/FORMOTEROL FUM) | 170 of 300 | 150 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
25 STIOLTO RESPIMAT (TIOTROPIUM BR/OLODATEROL HCL) | 370 of 580 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
26 SULFAMETHOXAZOLE-TRIMETHOPRIM (SULFAMETHOXAZOLE/TRIMETHOPRIM) | 180 of 270 | 130 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | A |
27 ONDANSETRON HCL | 30 of 80 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
28 LEVOFLOXACIN | 250 of 580 | 200 prescriptions Less than 1% of all prescriptions | | 190 patients 7% of all patients | < 11 | A |
29 CEFDINIR | 110 of 160 | 130 prescriptions Less than 1% of all prescriptions | | 110 patients 4% of all patients | < 11 | A |